We know that a vaccine for COVID-19 is probably still a year and a half away.

But could a small British startup have a solution that stops people dying in the meantime.

We are actually a small UK biotech company

that's trying to face one of the biggest healthcare challenges

that we've ever faced.

And could the trial of it in Italy... care challenges that we've ever faced.

And could the trial of it in Italy spell hope for life returning to normal in the UK?

If those on-ventilates are less likely to die, then obviously that's a great thing and this is one of many drugs that are hoping to do exactly that and in doing so find a way that the world's health services can avoid collapse.

You're listening to stories of our times from the Times and the Sunday Times.

I'm Manveen Rana. Today, the search for a remedy. We meet the man solutions to the coronavirus crisis.

Hydroxylchloricine, hydroxylauricine.

Today we wanted to try to understand some of them and to do this we need to get a bit

sciencey.

We don't have time to go and say, gee let's take a couple of years and test it out and

let's go and test with the test tubes and the laboratories.

At the age of 30, Samizidu is part of some rather hopeful new developments.

He's the co-founder and CEO of Isana Bioscience.

We're a small UK biotech company that's now just launched our first clinical trial

in severe COVID patients in Italy.

If we have any possible chance of helping those great heroes on the front line,

we should do everything we can to help.

There are a few medical strategies to tackle COVID-19.

...